共 50 条
- [35] OnabotulinumtoxinA (botulinum toxin type A) for the treatment of Japanese patients with overactive bladder and urinary incontinence: Results of single-dose treatment from a phase III, randomized, double-blind, placebo-controlled trial (interim analysis) INTERNATIONAL JOURNAL OF UROLOGY, 2020, 27 (03) : 227 - 234
- [38] Re: OnabotulinumtoxinA Improves Health-Related Quality of Life in Patients with Urinary Incontinence due to Idiopathic Overactive Bladder: A 36-Week, Double-Blind, Placebo-Controlled, Randomized, Dose-Ranging Trial Editorial Comment - Re: Onabotulinumtoxin A for Idiopathic Overactive Bladder: Raising the Bar Editorial Comment JOURNAL OF UROLOGY, 2013, 189 (06): : 2205 - 2206